Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Sep;32(3):307-10.

Determination of baseline antibody titre to S. typhi/paratyphi in Ile-Ife, Nigeria

Affiliations
  • PMID: 15030094

Determination of baseline antibody titre to S. typhi/paratyphi in Ile-Ife, Nigeria

S B Zailani et al. Afr J Med Med Sci. 2003 Sep.

Abstract

The aim of the study is to determine the baseline antibody titres to Salmonella typhi/paratyphi in healthy individuals with a view to establishing the significant titre for Widal agglutination test in Ile-Ife, Western Nigeria. Three hundred and ten healthy volunteers were admitted into the study and forty-eight clinically diagnosed and culture positive cases of Enteric fever were used as purposeful controls. Widal test was performed on each serum. Slide agglutination test was first done, then positive samples were further subjected to tube agglutination for quantitative titration. Of the 310 healthy volunteers, 274 (97.2%) had reciprocal antibody titre of < or = 80 to O antigen and 265 (95.0%) had reciprocal antibody titre of < or = 80 to H. antigen of S. typhi. On the other hand, in 48 control cases, 43 (89.6%) had reciprocal antibody titre of > or = 160 to O antigen and 38 (78.2%) had reciprocal titre of > or = 160 to H. antigen. The sensitivity and specificity of the test were 89.9% and 94.2% for O antibody, and 79.2% and 92.3% for H. antibody respectively. The baseline titre to S. typhi/paratyphi for both O & H antibody is 1:80 whilst the significant titre for O & H antibodies is 1:160 and above in Ile-Ife, Nigeria.

PubMed Disclaimer

Substances